Latest

Datavault AI Inc. (NASDAQ: DVLT) Announces a Distribution Date of Dec. 24, 2025, for the Dream Bowl Meme Coin Tokens to All Eligible Record Equity Holders of Datavault AI and Holders of Common Stock of Scilex Holding Company

Friday, 12 Dec 2025 5:52PM

PHILADELPHIA, Dec 12 (Bernama-GLOBE NEWSWIRE) -- via IBN-- Datavault AI Inc. (NASDAQ: DVLT)&nbs...

See More
Patton 荣获创新者奖金奖

Friday, 12 Dec 2025 4:57PM

《Cabling Installation & Maintenance》将 Patton 的 CopperLink® CL-SFP 以太网延长器...

See More

Other Press Release

Hytera's 5G Body Camera To Revolutionize Digital Evidence Acquisition And Management

Thursday, 24 Oct 2024 12:00AM

New Smart SC Series Body Camera (Photo: Business Wire) SHENZHEN, China, Oct 24 (Bernama-BUSINES...

See More
EBC Financial Group 扩大与 DiNapoli 领先指标的合作伙伴关系,揭示应对黑天鹅事件的关键策略

Thursday, 24 Oct 2024 12:00AM

台北,台湾, Oct 24 (Bernama-GLOBE NEWSWIRE) -- EBC Financial Group (EB...

See More
NTIS MARKS 3 YEARS OF EMPOWERING TECHNOLOGICAL GROWTH

Thursday, 24 Oct 2024 12:00AM

Opening Speech by YB. Dato' Haji Mohammad Yusof Bin ApdalDeputy Minister Of Science, Technology ...

See More
OPUS International And HSS Engineering Forge Strategic Joint Venture To Lead Infrastructure Development Across Southeast Asia And Middle East

Wednesday, 23 Oct 2024 12:00AM

 Ir. Sharifah Azlina Raja Kamal Pasmah, CEO, HSS Engineers Bhd and Tan Sri Ir. Kuna Sittampalam...

See More
NIQ Launches Marketing Mix Modeling Solutions, Expanding Its Media Division

Wednesday, 23 Oct 2024 12:00AM

Best-In-Class Proprietary granular store level dataIndependent global expertise with local footprint...

See More
Hytera To Revolutionize Mobile Workforce Communication By Launching P5 Series PoC Radio

Wednesday, 23 Oct 2024 12:00AM

Hytera's newly released PoC P5 Series Radio (Graphic: Business Wire)  SHENZHEN, China,...

See More
Jumio Leads With Innovation By Announcing Over 300 Patents And Patent Applications

Wednesday, 23 Oct 2024 12:00AM

 (Graphic: Business Wire)Company’s expansive portfolio covers wide-ranging and advanced i...

See More
Recursion Announces First Patient Dosed In Phase 2 Clinical Study Of REC-3964, A Potential First-in-class, Oral, Non-antibiotic Small Molecule For Recurrent Clostridioides Difficile Infection

Wednesday, 23 Oct 2024 12:00AM

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS.REC-3964 rep...

See More